Georg Arnold Bjarnason
5PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.Pedro Barata, Catherine Tangen, Melissa Plets
|Aug 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh
|Jan 21, 2022
The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance.Harrison Sicheng Lin, Qiang Ding, Zsuzsanna Lichner
|Feb 02, 2021
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma.David F McDermott, Jae-Lyun Lee, Marek Ziobro
|Feb 02, 2021
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.David F McDermott, Jae-Lyun Lee, Georg A Bjarnason
Pageof 1
Frequent Collaborators
2 joint publications
David F McDermott
2 joint publications
Jae-Lyun Lee
2 joint publications
Rustem Airatovich Gafanov
2 joint publications
Frede Donskov
2 joint publications
Charles Schloss
1 joint publications
James M G Larkin
1 joint publications
Marek Ziobro
1 joint publications
Vsevolod Borisovich Matveev
1 joint publications
Lori Wood
1 joint publications
Frederic Pouliot
